Patents by Inventor Spencer John Williams

Spencer John Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imaging composition and uses thereof
    Patent number: 11123316
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Grant
    Filed: April 8, 2020
    Date of Patent: September 21, 2021
    Assignee: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • NOVEL IMAGING COMPOSITION AND USES THEREOF
    Publication number: 20200246286
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Application
    Filed: April 8, 2020
    Publication date: August 6, 2020
    Inventors: Paul Stephen DONNELLY, Stacey Erin RUDD, Spencer John WILLIAMS
  • Imaging composition and uses thereof
    Patent number: 10653649
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: May 19, 2020
    Assignee: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • Sodium channel modulators
    Patent number: 10577308
    Abstract: The present disclosure relates generally to compounds having activity as voltage-gated sodium channel blockers and their use in the field of therapeutic treatment, including the therapy or management of conditions associated with excessive, unwanted, inadequate or otherwise undesirable sodium ion passage through cellular membranes via voltage-gated sodium channels. In some embodiments, the disclosure relates to aryloxy-substituted amines for use as sodium channel blockers or modulators. Methods for their manufacture and compositions containing the compounds are also disclosed.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: March 3, 2020
    Assignees: The Florey Institute, The University of Melbourne
    Inventors: Spencer John Williams, Bevyn Jarrott
  • NOVEL IMAGING COMPOSITION AND USES THEREOF
    Publication number: 20200009090
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Application
    Filed: July 15, 2019
    Publication date: January 9, 2020
    Inventors: Paul Stephen DONNELLY, Stacey Erin RUDD, Spencer John WILLIAMS
  • Imaging composition and uses thereof
    Patent number: 10398660
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal center, particularly for the imaging of tumors.
    Type: Grant
    Filed: April 26, 2018
    Date of Patent: September 3, 2019
    Assignee: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • NOVEL IMAGING COMPOSITION AND USES THEREOF
    Publication number: 20190099392
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Application
    Filed: April 26, 2018
    Publication date: April 4, 2019
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • Imaging composition and uses thereof
    Patent number: 9980930
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: May 29, 2018
    Assignee: The University of Melbourne
    Inventors: Paul Stephen Donnelly, Stacey Erin Rudd, Spencer John Williams
  • Fused ring analogues of anti-fibrotic agents
    Patent number: 9951087
    Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: April 24, 2018
    Assignee: Fibrotech Therapeutics PTY LTD
    Inventors: Spencer John Williams, Steven Zammit, Darren James Kelly
  • Sodium Channel Modulators
    Publication number: 20180072656
    Abstract: The present disclosure relates generally to compounds having activity as voltage-gated sodium channel blockers and their use in the field of therapeutic treatment, including the therapy or management of conditions associated with excessive, unwanted, inadequate or otherwise undesirable sodium ion passage through cellular membranes via voltage-gated sodium channels. In some embodiments, the disclosure relates to aryloxy-substituted amines for use as sodium channel blockers or modulators. Methods for their manufacture and compositions containing the compounds are also disclosed.
    Type: Application
    Filed: March 24, 2016
    Publication date: March 15, 2018
    Inventors: Spencer John Williams, Bevyn Jarrot
  • NOVEL IMAGING COMPOSITION AND USES THEREOF
    Publication number: 20170326084
    Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
    Type: Application
    Filed: October 16, 2015
    Publication date: November 16, 2017
    Inventors: Paul Stephen DONNELLY, Stacey Erin RUDD, Spencer John WILLIAMS
  • Therapeutic compounds
    Patent number: 9561201
    Abstract: Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogs thereof, pharmaceutically acceptable salts thereof, and metabolites thereof, with the proviso that the compound is no Tranilast.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: February 7, 2017
    Assignee: Fibrotech Therapeutics PTY LTD
    Inventors: Spencer John Williams, David Stapleton, Steven Zammit, Darren James Kelly, Richard Ernest Gilbert, Henry Krum
  • FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
    Publication number: 20150266893
    Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.
    Type: Application
    Filed: June 4, 2015
    Publication date: September 24, 2015
    Applicant: Fibrotech Therapeutics PTY LTD
    Inventors: Spencer John Williams, Steven Zammit, Warren James Kelly
  • Fused ring analogues of anti-fibrotic agents
    Patent number: 9062076
    Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: June 23, 2015
    Assignee: Fibrotech Therapeutics PTY LTD
    Inventors: Spencer John Williams, Steven Zammit, Darren James Kelly
  • THERAPEUTIC COMPOUNDS
    Publication number: 20140357628
    Abstract: Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof, with the proviso that the compound is no Tranilast.
    Type: Application
    Filed: June 27, 2014
    Publication date: December 4, 2014
    Applicant: Fibrotech Therapeutics Pty Ltd
    Inventors: Spencer John Williams, David Stapleton, Steven Zammit, Darren James Kelly, Richard Ernest Gilbert, Henry Krum
  • Halogenated analogues of anti-fibrotic agents
    Patent number: 8624056
    Abstract: The present invention relates to halogenated compounds of formula (I) with the substituents as described within the specification. The compounds may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: January 7, 2014
    Inventors: Darren James Kelly, Spencer John Williams, Steven Zammit
  • FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
    Publication number: 20130338151
    Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.
    Type: Application
    Filed: October 21, 2010
    Publication date: December 19, 2013
    Applicant: Fibrotech Therapeutics Pty Ltd
    Inventors: Spencer John Williams, Steven Zammit, Darren James Kelly
  • FUSED RING ANALOGUES OF ANTI-FIBROTIC AGENTS
    Publication number: 20120270863
    Abstract: The present invention relates to arylcarbonyl and heteroarylcarbonyl anthranilate compounds that may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment disorders.
    Type: Application
    Filed: October 21, 2010
    Publication date: October 25, 2012
    Applicant: Fibrotech Therapeutics Pty Ltd
    Inventors: Spencer John Williams, Steven Zammit, Darren James Kelly
  • HALOGENATED ANALOGUES OF ANTI-FIBROTIC AGENTS
    Publication number: 20120059188
    Abstract: The present invention relates to halogenated compounds of formula (I) with the substituents as described within the specification. The compounds may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation.
    Type: Application
    Filed: December 19, 2008
    Publication date: March 8, 2012
    Applicants: The University of Melbourne, Fibrotech Therapeutics Pty Ltd
    Inventors: Darren James Kelly, Spencer John Williams, Steven Zammit
  • HALOGENATED ANALOGUES OF ANTI-FIBROTIC AGENTS
    Publication number: 20110021815
    Abstract: The present invention relates to halogenated compounds of formula (I) with the substituents as described within the specification. The compounds may be useful as anti-fibrotic agents. The present invention also relates to methods for their preparation.
    Type: Application
    Filed: December 19, 2008
    Publication date: January 27, 2011
    Applicants: Fibrotech Therapeutics Pty Ltd, The University of Melbourne
    Inventors: Darren James Kelly, Spencer John Williams, Steven Zammit